Clinical Trial Update: Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab in Solid Tumors [Phase 2]

View source ↗

Summary

This is a Phase II multicohort trial assessing sEphB4-HSA in combination with pembrolizumab for solid tumors; the study is currently active but not recruiting, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Prostate Cancer
• Urothelial Carcinoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)
• sEphB4-HSA

Snippet

Sponsor: University of Southern California | Conditions: Stage IV Bladder Urothelial Carcinoma, Prostate Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING